These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27260141)

  • 1. The B-cell response to foot-and-mouth-disease virus in cattle following vaccination and live-virus challenge.
    Grant CFJ; Carr BV; Singanallur NB; Morris J; Gubbins S; Hudelet P; Ilott M; Charreyre C; Vosloo W; Charleston B
    J Gen Virol; 2016 Sep; 97(9):2201-2209. PubMed ID: 27260141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of high-potency FMDV O
    Horsington J; Perez CB; Maradei E; Novo SG; Gonzales JL; Singanallur NB; Bonastre P; Vosloo W
    Vaccine; 2017 Sep; 35(38):5179-5185. PubMed ID: 28789849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.
    Nagendrakumar SB; Srinivasan VA; Madhanmohan M; Yuvaraj S; Parida S; Di Nardo A; Horsington J; Paton DJ
    Vaccine; 2011 Feb; 29(10):1906-12. PubMed ID: 21236232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine.
    Horsington J; Zhang Z; Bittner H; Hole K; Singanallur NB; Alexandersen S; Vosloo W
    Vaccine; 2015 Jan; 33(3):422-9. PubMed ID: 25483241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig.
    Kim T; Hong JK; Oem JK; Lee KN; Lee HS; Kim YJ; Ryoo S; Ko YJ; Park JH; Choi J; Lee SH; Jo HJ; Lee MH; Kim B; Kim J
    Vaccine; 2019 Mar; 37(12):1702-1709. PubMed ID: 30712811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The B Cell Response to Foot-and-Mouth Disease Virus in Cattle following Sequential Vaccination with Multiple Serotypes.
    Grant CFJ; Carr BV; Kotecha A; van den Born E; Stuart DI; Hammond JA; Charleston B
    J Virol; 2017 May; 91(9):. PubMed ID: 28228594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes.
    Höhlich BJ; Wiesmüller KH; Haas B; Gerner W; Correa R; Hehnen HR; Schlapp T; Pfaff E; Saalmüller A
    J Gen Virol; 2003 Dec; 84(Pt 12):3315-3324. PubMed ID: 14645912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage.
    Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    Antiviral Res; 2020 Oct; 182():104920. PubMed ID: 32828822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T
    Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
    PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV.
    Guzman E; Taylor G; Charleston B; Skinner MA; Ellis SA
    J Gen Virol; 2008 Mar; 89(Pt 3):667-675. PubMed ID: 18272757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with foot-and-mouth disease virus (FMDV) induces a natural killer (NK) cell response in cattle that is lacking following vaccination.
    Patch JR; Dar PA; Waters R; Toka FN; Barrera J; Schutta C; Kondabattula G; Golde WT
    Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):249-57. PubMed ID: 25150134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
    Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Response and Partial Protection against Heterologous Foot-and-Mouth Disease Virus Induced by Dendrimer Peptides in Cattle.
    Soria I; Quattrocchi V; Langellotti C; Pérez-Filgueira M; Pega J; Gnazzo V; Romera S; Schammas J; Bucafusco D; Di Giacomo S; de la Torre BG; Andreu D; Sobrino F; Blanco E; Zamorano P
    J Immunol Res; 2018; 2018():3497401. PubMed ID: 29854834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a high potency O
    Fishbourne E; Ludi AB; Wilsden G; Hamblin P; Statham B; Bin-Tarif A; Brocchi E; Grazioli S; Dekker A; Eblé P; King DP
    Vaccine; 2017 May; 35(20):2761-2765. PubMed ID: 28396208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.